Argent Trust Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.1M Buy
180,576
+968
+0.5% +$225K 1.5% 9
2025
Q4
$37.2M Sell
179,608
-1,682
-0.9% -$333K 1.27% 14
2025
Q3
$33.6M Buy
181,290
+4,349
+2% +$745K 1.19% 16
2025
Q2
$27M Buy
176,941
+3,080
+2% +$473K 1.02% 18
2025
Q1
$28.8M Buy
173,861
+1,557
+0.9% +$244K 1.18% 14
2024
Q4
$24.9M Buy
172,304
+686
+0.4% +$106K 1.02% 19
2024
Q3
$27.8M Sell
171,618
-17,977
-9% -$2.86M 1.15% 16
2024
Q2
$27.7M Buy
189,595
+963
+0.5% +$143K 1.22% 13
2024
Q1
$29.8M Sell
188,632
-3,563
-2% -$567K 1.34% 10
2023
Q4
$30.1M Buy
192,195
+5,471
+3% +$839K 1.5% 10
2023
Q3
$29.1M Buy
186,724
+2,547
+1% +$420K 1.59% 8
2023
Q2
$30.5M Buy
184,177
+14,162
+8% +$2.29M 1.65% 7
2023
Q1
$26.4M Buy
170,015
+4,435
+3% +$716K 1.67% 7
2022
Q4
$29.2M Buy
165,580
+1,661
+1% +$287K 1.93% 6
2022
Q3
$26.8M Buy
163,919
+2,555
+2% +$432K 1.94% 4
2022
Q2
$28.6M Buy
161,364
+2,102
+1% +$375K 1.97% 4
2022
Q1
$28.2M Sell
159,262
-101
-0.1% -$17.2K 1.72% 7
2021
Q4
$27.3M Buy
159,363
+503
+0.3% +$82.3K 1.6% 8
2021
Q3
$25.7M Buy
158,860
+5,906
+4% +$1.01M 1.65% 7
2021
Q2
$25.2M Buy
152,954
+2,394
+2% +$396K 1.65% 6
2021
Q1
$24.7M Buy
150,560
+5,566
+4% +$901K 1.74% 4
2020
Q4
$22.8M Buy
144,994
+6,994
+5% +$1.03M 1.76% 4
2020
Q3
$20.5M Buy
138,000
+2,659
+2% +$393K 1.81% 5
2020
Q2
$19M Buy
135,341
+6,095
+5% +$888K 1.78% 4
2020
Q1
$16.9M Buy
129,246
+5,153
+4% +$731K 1.9% 4
2019
Q4
$18.1M Buy
124,093
+716
+0.6% +$97.1K 1.61% 4
2019
Q3
$16M Buy
123,377
+822
+0.7% +$108K 1.54% 7
2019
Q2
$17.1M Sell
122,555
-175
-0.1% -$24.2K 1.73% 6
2019
Q1
$17.2M Buy
122,730
+756
+0.6% +$101K 1.8% 6
2018
Q4
$15.7M Sell
121,974
-2,214
-2% -$309K 1.85% 6
2018
Q3
$17M Sell
124,188
-1,136
-0.9% -$151K 1.96% 6
2018
Q2
$15.2M Buy
125,324
+68,641
+121% +$8.56M 1.85% 8
2018
Q1
$7.26M Buy
56,683
+32,871
+138% +$4.44M 2.08% 8
2017
Q4
$3.33M Sell
23,812
-2,091
-8% -$291K 1.3% 13
2017
Q3
$3.37M Buy
25,903
+258
+1% +$34.2K 1.33% 13
2017
Q2
$3.39M Sell
25,645
-1,164
-4% -$148K 1.4% 11
2017
Q1
$3.34M Sell
26,809
-517
-2% -$61.8K 1.38% 13
2016
Q4
$3.15M Sell
27,326
-7,738
-22% -$894K 1.39% 12
2016
Q3
$4.14M Sell
35,064
-4,029
-10% -$489K 1.76% 7
2016
Q2
$4.74M Buy
39,093
+238
+0.6% +$27K 2.09% 5
2016
Q1
$4.2M Sell
38,855
-243
-0.6% -$25.2K 2.04% 5
2015
Q4
$4.02M Buy
39,098
+9,801
+33% +$986K 2% 5
2015
Q3
$2.73M Buy
29,297
+33
+0.1% +$3.19K 1.55% 8
2015
Q2
$2.85M Sell
29,264
-2,281
-7% -$228K 1.44% 8
2015
Q1
$3.17M Buy
31,545
+216
+0.7% +$22K 1.6% 6
2014
Q4
$3.28M Buy
+31,329
New +$3.3M 1.97% 5

Other funds holding JNJ

Argent Trust Co's JNJ Position: Q1 2026 in Review

Argent Trust Co increased its Johnson & Johnson (JNJ) stake by 0.54% in Q1 2026, buying an estimated $225K and bringing the position to 180,576 shares worth $44.1M. The position accounts for 1.5% of the portfolio, ranked #9.

Argent Trust Co first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Argent Trust Co held 180,576 shares of Johnson & Johnson worth $44.1M as of Q1 2026.
  • Argent Trust Co bought 968 Johnson & Johnson shares in Q1 2026, an estimated $225K.
  • Johnson & Johnson made up 1.5% of Argent Trust Co's portfolio in Q1 2026, its #9 holding.
  • Argent Trust Co first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.